Eurazeo SE
PAR:RF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Eurazeo SE
Cash & Cash Equivalents
Eurazeo SE
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Eurazeo SE
PAR:RF
|
Cash & Cash Equivalents
€106.6m
|
CAGR 3-Years
-53%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
-21%
|
|
|
Wendel SE
PAR:MF
|
Cash & Cash Equivalents
€3.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
2%
|
CAGR 10-Years
10%
|
|
|
Peugeot Invest SA
PAR:PEUG
|
Cash & Cash Equivalents
€197m
|
CAGR 3-Years
41%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Financiere Moncey SA
PAR:FMONC
|
Cash & Cash Equivalents
€13.3m
|
CAGR 3-Years
59%
|
CAGR 5-Years
29%
|
CAGR 10-Years
-1%
|
|
Eurazeo SE
Glance View
Eurazeo SE, a prominent player in the European investment landscape, is a renowned growth and private equity firm that has successfully carved out a niche in nurturing companies across varied sectors. Established in 2001 from the merger of Azeo and Eurafrance, the company emerged as a potent financial powerhouse, adept at transforming businesses into industry leaders. Eurazeo stands out for its dynamic approach to investment, leveraging its substantial capital and resources to enable businesses to scale and thrive. The firm's diversified portfolio reflects its strategic acumen in identifying and nurturing potential in industries ranging from healthcare and real estate to digital technologies and financial services. The company's unique operational model revolves around active value creation, offering more than just capital. Eurazeo brings to the table its extensive network, strategic guidance, and expert insights, helping portfolio companies improve their operations, expand market reach, and foster innovation. With a significant portion of its earnings sourced from the long-term appreciation of these investments, Eurazeo capitalizes on its adeptness at timing the market. They carefully manage exits, often through public offerings or private sales, reaping substantial returns. Their success in orchestrating such exits underlines Eurazeo's adeptness in navigating the complexities of the investment landscape, consistently generating robust returns for its stakeholders.
See Also
What is Eurazeo SE's Cash & Cash Equivalents?
Cash & Cash Equivalents
106.6m
EUR
Based on the financial report for Dec 31, 2025, Eurazeo SE's Cash & Cash Equivalents amounts to 106.6m EUR.
What is Eurazeo SE's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
-21%
Over the last year, the Cash & Cash Equivalents growth was 29%. The average annual Cash & Cash Equivalents growth rates for Eurazeo SE have been -53% over the past three years , -38% over the past five years , and -21% over the past ten years .